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Background: In anticipation of vaccine introduction, we assessed epidemiology of rotavirus disease among
children visiting medical centre due to acute diarrhoea in Ouagadougou, Burkina Faso.
Methods: Between November 2008 and February 2010, stool specimens from 447 children less than 5 years of age
suffering from diarrhoea were tested for the presence of rotavirus by antigen detection using an
immunochromatographic test. Sociodemographic, environmental and clinical factors were assessed during the
study.
Results: Rotavirus antigen was detected in 151 (33.8%) of the patients. Most of the cases (94.2%) were in children
< 24 months of age. Fever and vomiting were the symptoms most commonly reported in association with
rotavirus diarrhoea and the patients were often hospitalized. Rotavirus-associated diarrhoea occurred mostly during
the season from December to April (dry season). Rotavirus infection was significantly less frequent in breast-fed
than among bottle-fed babies.
Conclusions: The results of this study underscore the need to control rotavirus infections among young children
in Burkina Faso and may argue a decision on the introduction of rotavirus vaccine in Burkina Faso.
Background
Rotavirus is a major cause of acute gastroenteritis in
infants and young children worldwide [1]. It has been
estimated that about 39% of childhood diarrhoea hospita-
lizations are caused by rotaviruses and nearly half a mil-
lion children die from rotavirus infections each year [2].
Furthermore, rotavirus mortality is concentrated in the
developing countries on the Asian subcontinent, Africa,
and Latin America where access to health care facilities is
limited [3]. This may result in a significant disease bur-
den and economic effect of direct medical costs, loss of
work, quality of life and mortality. In other diarrhoeal
diseases, improvement of hygiene and sanitation may
reduce the incidence, but these measures are unlikely suf-
ficient for rotavirus control. Vaccination is the only con-
trol measure likely to have a significant impact on the
incidence of severely dehydrating rotavirus disease [4].
Two new live-attenuated rotavirus vaccines (Rotarix® and
RotaTeq®) have demonstrated very good safety and effi-
cacy profiles in large clinical trials in the Western indus-
trialized countries and in Latin America [5-9]. Trials on
these vaccines are now in progress in sub-Saharan Africa
to assess their effectiveness and efficacy.
In Burkina Faso, very few data on illness caused by
rotavirus have been published and these studies indi-
cated that 14% of acute diarrhoea in children under the
age of 5 years is due to rotavirus infection but epide-
miological data are still incomplete [10].
The objectives of this study were to describe, for the
first time, epidemiology of rotavirus disease among chil-
dren visiting a local health centre because of acute gas-
troenteritis in Ouagadougou in Burkina Faso to provide
background knowledge on the disease before vaccine
introduction and to inform the policy makers on the
need for the introduction of new rotavirus vaccines.
Methods
Study population and specimens
The study was conducted at Centre Médical avec
Antenne Chirugicale (CMA) du Secteur 30 in the capital
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located in the Bogodogo district is one of the four sec-
ondary health care centers in Ouagadougou and its pae-
diatric ward has a capacity of 30 beds and admits over
2260 children each year. Ouagadougou has a population
of nearly two millions, whereas the Bogodogo district
has a population of about 548000 with 81000 (15%) chil-
dren < 5 years of age http://www.sante.gov.bf. The study
protocol was approved by the Ethics Committee of
Burkina Faso. Parents of all the paediatric patients were
informed on the study details and their oral consent was
obtained before stool specimen and epidemiological data
collection during the course of treatment. Written con-
sent was obtained from parents of the control group. All
children under the age of 5 year visiting the paediatric
service for treatment of gastroenteritis from November
2008 to February 2010 were included in the study. Diar-
rhoea was defined as the passage of three or more loose
or watery stools in the preceding 24 h. During this
study, 471 patients were included as soon as they were
seen by a physician and fresh stool samples were col-
lected and transferred to the Microbiology Laboratory at
the National Public Health Laboratory, Ouagadougou,
for rotavirus and adenovirus detection. Control stool
samples were collected from 60 randomly selected chil-
dren coming to the same health centre for routine
immunization and not presenting gastroenteritis symp-
toms. The age of the control was paired with the
patient’s age. Information regarding the age, sex, type of
nutrition (breast-fed and/or bottle-fed), hospitalization
and clinical symptoms such as fever, vomiting and dehy-
dration, and the characteristics of stool were recorded
for each child. Also hygiene factors such as source of
drinking water of the child were collected during the
study.
Detection of rotavirus in stool samples
All stool samples were analyzed for group A rotavirus
using one step rotavirus and adenovirus serotypes 40/41
test for determination of rotavirus and adenovirus in
human feces (SD Bioline Rota/Adeno®; Standard diag-




2 test was used to analyze the data and the p value less
than 0.05 was considered statistically significant.
Results
Rotavirus prevalence
Out of the 471 children with acute diarrhea initially
included in the study, 24 were subsequently excluded
because for 19 of them no sample was collected and for
5 of them no epidemiological data were available. Of the
447 stool specimens analysed, 151 (33.8%) were found
to contain rotavirus. Only one (1.7%) out of the 60 stool
specimens collected from healthy children was positive
by immunochromatographic test (ICG) (p < 0.0001).
Adenovirus was detected in 17 of 447 (3.8%) stool sam-
ples and mixed infections with both rotavirus and ade-
novirus were observed in 11 (2.5%) stool samples.
Age and sex distribution of patients with rotavirus
infection
The age distribution of children with rotavirus is shown
in Figure 1. Most cases of rotavirus infection (94.2%)
occurred among children less than 2 years of age. The
highest incidence was observed in children between 6
and 11 months of age. The median age for rotavirus
infection was 8 months. There were more males (52.8%)
than females, but the sex ratio among the rotavirus diar-
rhea patients was not significant (p = 0.1).
Seasonal distribution of rotavirus infections
During the whole period of surveillance, the incidence
of rotavirus infections varied significantly according to
seasons (warm and cold) (p = 0.0001). Rotavirus infec-
tions occurred mostly during the season from December
to April, corresponding to the dry season and relatively
cold period (Figure 2).
Hospitalization and clinical presentation of rotavirus
infection
Of the 217 outpatient children, 48 (22.1%) were infected
and of the 230 inpatient children, 103 (44.8%) were
infected with rotavirus. The rotavirus infection preva-
lence was significantly higher among hospitalized chil-
dren (p = 0.0001) illustrating a significant relationship
between rate of hospitalization - severity of illness and
diarrhoea associated with rotavirus infection. In addi-
tion, fever was the symptom most commonly reported
in association with rotavirus diarrhoea (82.1%), followed
by vomiting (72.8%) and dehydration (48.3%) (Table 1).
Nutrition and drinking water
Among the infants ≤ 9m o n t h so fa g e ,w h oh a dr o t a -
virus diarrhoea and for whom the method of feeding
was recorded, 55 out of 154 were breast-fed (35.7%) and
32 out of 61 were bottle-fed (52.5%) (p = 0.01). Analysis
o fh y g i e n ef a c t o r ss u c ha st h es o u r c eo fd r i n k i n gw a t e r
showed that children drinking municipal water were
more affected by rotavirus diarrhoea than children
drinking mineral water sold in bottles (p = 0.0001)
(Table 1).
Discussion
This was the first study in Burkina Faso to investigate
the prevalence, clinical characteristic and risk factors of
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results, rotavirus diarrhoea appears to be a major public
health problem for children in Burkina Faso, as in the
other developing countries. Our results show that a sig-
nificant proportion of acute diarrhoea is due to rotavirus
(33.8%) and rotavirus may be responsible for almost
one-half (44.8%) of all hospitalizations for diarrhea in
children < 5 years of age in Burkina Faso. The detected
prevalence appears to be similar to those reported from
other West African countries, which ranged from 33%
to 39% [11-13]. In addition, a cumulative experience
from 15 African countries suggested that rotavirus is the
most important cause of severe diarrhoea in African
children [14].
As observed in the other parts of the world, the bur-
den of rotavirus disease is predominantly borne by chil-
dren less than 2 years of age [15] with a high incidence
among children 6-11 months of age. This can be
explained by the protective effect of maternal antibodies
in < 6 months old, and the development of natural
immunity after repeated infections in children over
2 years of age [16,17].
Our results showed that rotavirus occurred mostly
during the season from December to April, correspond-
ing to the dry season and relatively cold period, as has
been reported from Northern Ghana near Burkina Faso
[13] and Guinea-Bissau [11]. Some studies conducted in
other African countries indicated that rotavirus infec-
tions are present throughout the year, but with much
higher prevalence in a certain period of a year [14].
Comparison of the clinical characteristics and severity
of the acute gastroenteritis among the rotavirus-positive
and rotavirus-negative patients indicated that vomiting,
fever and dehydration were more frequently observed
among diarrheal children with rotavirus than among
those without rotavirus infection, as reported in the
other countries [11,18].
Our confirmation of a previous observation made in
the other parts of the world that during the first year of
life breastfeeding is associated with a lower incidence
of rotavirus diarrhoeal episodes adds to the multitude of
benefits that have been associated with breastfeeding
[19,20]. In addition, it has been shown that even if the
breast-fed infants get infected with rotavirus, a milder
disease occurs and hospitalization rate is significantly
lower [21].
Another important issue, which was shown in this
study, is a significant association between rotavirus diar-
rhea and municipal drinking water. This may be due to
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Figure 1 Proportion of rotavirus infections by age groups among the 447 children suffering of gastroenteritis, between November
2008 to February 2010.
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Page 3 of 6Figure 2 Seasonality of the acute gastroenteritis and the rotavirus infections among the 447 children suffering of gastroenteritis,
between November 2008 to February 2010.
Table 1 Clinical and epidemiological features of children with and without rotavirus detected in the diarrheal stool
sample
Epidemiological and clinical characteristics Rotavirus Diarrhea Non Rotavirus Diarrhea p
(N = 151) (N = 296)
Sex
Male 71 (47.0%) 165 (55.7%) p = 0.1
Female 80 (53.0%) 131 (44.8%)
Mean age (months) 10.9 16.6
Patient status
Inpatient 103 (44.8%) 127 (55.2%) p = 0.0001
Outpatient 48 (22.1%) 169 (77.9%)
Symptom
Fever 124 (82.1%) 161 (54.4%) p = 0.0001
Vomiting 110 (72.8%) 80 (27.0%) p = 0.0001
Dehydration 73 (48.3%) 54 (18.2%) p = 0.0001
Season*
Warm 5 (2.9%) 168 (97.1%) p = 0,0001
Cold 146 (53.3%) 128 (46.7%)
Breast feeding**
Yes 59 (59.0%) 105 (75.5%) p = 0.010
No 41 (41.0%) 34 (24.5%)
Drinking water source
Municipal supply 108 (71.5%) 142 (48.0%) p = 0.0001
Bottled water 43 (28.5%) 154 (52.0%)
*Percentage of rotavirus diarrhea versus non-rotavirus diarrhea for both seasons.
**Percentage of rotavirus diarrhea versus non-rotavirus diarrhea according to method of feeding among infants ≤ 9 months of age.
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which drinking water may be a potential risk of rota-
virus transmission. Rotavirus has been described as a
causative agent in several waterborne outbreaks in the
industrialized countries [22-25], indicating good survival
of rotavirus in water. In Burkina Faso, the evaluation of
drinking water quality does not require testing for rota-
virus but our results show the importance of including
routine virological analysis of drinking water during
rotavirus season.
Conclusions
In conclusion, this study provides information on the
epidemiology and the extent of rotavirus infections in
Burkina Faso. Our results indicate that gastroenteritis
caused by rotavirus in the country is an important
health problem, particularly among children less than
2 years of age and during the cold season. These data
will be useful for making an informed decision about
the introduction of rotavirus vaccine in Burkina Faso
and will provide a baseline against which the impact of
the vaccine introduction can be measured in the future.
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